Departments of Medicine (R.Y., M.P., L.D.Q.) and Pharmacology (S.W.B.), University of Tennessee Health Science Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt (M.M.N.).
Departments of Medicine (R.Y., M.P., L.D.Q.) and Pharmacology (S.W.B.), University of Tennessee Health Science Center, Memphis, Tennessee; and Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt (M.M.N.)
Mol Pharmacol. 2019 May;95(5):563-572. doi: 10.1124/mol.118.115014. Epub 2019 Mar 20.
G protein-coupled receptor family C group 6 member A (GPRC6A) is activated by testosterone and modulates prostate cancer progression. Most humans have a GPRC6A variant that contains a recently evolved KGKY insertion/deletion in the third intracellular loop (ICL3) (designated as GPRC6A) that replaces the ancestral KGRKLP sequence (GPRC6A) present in all other species. In vitro assays purport that human GPRC6A is retained intracellularly and lacks function. These findings contrast with ligand-dependent activation and coupling to mammalian target of rapamycin complex 1 (mTORC1) signaling of endogenous human GPRC6A in PC-3 cells. To understand these discrepant results, we expressed mouse (mGPRC6A), human (hGPRC6A), and humanized mouse (mGPRC6A) GPRC6A into human embryonic kidney 293 cells. Our results demonstrate that mGPRC6A acts as a classic G protein-coupled receptor, which is expressed at the cell membrane and internalizes in response to ligand activation by testosterone. In contrast, hGPRC6A and humanized mouse mGPRC6A are retained intracellularly in ligand naive cells, yet exhibit -arrestin-dependent signaling responses, mitogen-activated protein kinase [i.e., extracellular signal-regulated kinase (ERK)], and p70S6 kinase phosphorylation in response to testosterone, indicating that hGPRC6A is functional. Indeed, testosterone stimulates time- and dose-dependent activation of ERK, protein kinase B, and mTORC1 signaling in wild-type PC-3 cells that express endogenous GPRC6A In addition, testosterone stimulates GPRC6A-dependent cell proliferation in wild-type PC-3 cells and inhibits autophagy by activating mTORC1 effectors eukaryotic translation initiation factor 4E binding protein 1 and Unc-51 like autophagy activating kinase 1. Testosterone activation of GPRC6A has the obligate requirement for calcium in the incubation media. In contrast, in GPRC6A-deficient cells, the effect of testosterone to activate downstream signaling is abolished, indicating that human GPRC6A is required for mediating the effects of testosterone on cell proliferation and autophagy.
G 蛋白偶联受体家族 C 组 6 成员 A(GPRC6A)被睾酮激活,并调节前列腺癌的进展。大多数人具有一种 GPRC6A 变体,该变体在第三细胞内环(ICL3)中包含最近进化的 KGKY 插入/缺失(命名为 GPRC6A),取代了所有其他物种中存在的祖先 KGRKLP 序列(GPRC6A)。体外试验声称,人类 GPRC6A 被保留在细胞内并且缺乏功能。这些发现与配体依赖性激活和与哺乳动物雷帕霉素靶蛋白复合物 1(mTORC1)信号转导的内源性人类 GPRC6A 在 PC-3 细胞中的作用形成对比。为了理解这些差异的结果,我们将小鼠(mGPRC6A)、人类(hGPRC6A)和人源化小鼠(mGPRC6A)GPRC6A 表达到人胚肾 293 细胞中。我们的结果表明,mGPRC6A 作为一种经典的 G 蛋白偶联受体起作用,该受体在细胞膜上表达,并在配体激活时通过睾酮内化。相比之下,hGPRC6A 和人源化小鼠 mGPRC6A 在配体-naive 细胞中被保留在细胞内,但表现出 -arrestin 依赖性信号反应,丝裂原激活的蛋白激酶[即细胞外信号调节激酶(ERK)]和 p70S6 激酶磷酸化对睾酮的反应,表明 hGPRC6A 是有功能的。事实上,睾酮刺激野生型 PC-3 细胞中内源性 GPRC6A 的时间和剂量依赖性 ERK、蛋白激酶 B 和 mTORC1 信号转导的激活。此外,睾酮通过激活 mTORC1 效应物真核翻译起始因子 4E 结合蛋白 1 和非典型卷曲相关激酶 1 刺激野生型 PC-3 细胞中的 GPRC6A 依赖性细胞增殖并抑制自噬。GPRC6A 的睾酮激活需要孵育介质中的钙。相比之下,在 GPRC6A 缺陷细胞中,睾酮激活下游信号的作用被废除,表明人类 GPRC6A 是介导睾酮对细胞增殖和自噬作用所必需的。